ADA-话题@MedSci

#ADA#

386篇内容 | 3972人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1264499, encodeId=14c6126449937, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2014：计划委员会主席介绍大会热点, objectType=article, longId=36415, objectId=bbeb36415a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bbeb36415a8, replyNumber=0, likeNumber=46, createdTime=2014-06-15, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bbeb36415a8, moduleTitle=ADA 2014：计划委员会主席介绍大会热点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bbeb36415a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264498, encodeId=8e3b1264498d8, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=OCC 2014：方丕华教授谈Brugada综合征, objectType=article, longId=36182, objectId=bed336182e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bed336182e8, replyNumber=0, likeNumber=32, createdTime=2014-06-11, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bed336182e8, moduleTitle=OCC 2014：方丕华教授谈Brugada综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bed336182e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264496, encodeId=ada3126449670, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA2014精彩抢先知, objectType=article, longId=36174, objectId=7ecd361e4a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ecd361e4a1, replyNumber=0, likeNumber=37, createdTime=2014-06-11, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ecd361e4a1, moduleTitle=ADA2014精彩抢先知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ecd361e4a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264497, encodeId=a6bd126449e6b, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2014：降糖：脂肪肝新疗法？, objectType=article, longId=36177, objectId=acc7361e768, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acc7361e768, replyNumber=0, likeNumber=39, createdTime=2014-06-11, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acc7361e768, moduleTitle=ADA 2014：降糖：脂肪肝新疗法？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acc7361e768)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264493, encodeId=caa81264493e7, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2014：第四届ADA-CMT中国专场，欢迎您莅临！, objectType=article, longId=36067, objectId=87503606ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87503606ed0, replyNumber=0, likeNumber=33, createdTime=2014-06-07, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87503606ed0, moduleTitle=ADA 2014：第四届ADA-CMT中国专场，欢迎您莅临！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87503606ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264494, encodeId=7b5a1264494b5, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2014：中国成人糖尿病流行与控制现状研究, objectType=article, longId=36068, objectId=3e7436068e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e7436068e5, replyNumber=0, likeNumber=35, createdTime=2014-06-07, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e7436068e5, moduleTitle=ADA 2014：中国成人糖尿病流行与控制现状研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e7436068e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264495, encodeId=59c81264495c5, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2014：不同GADA滴度LADA患者胰岛β细胞功能变化观察（LADA China 3）研究, objectType=article, longId=36069, objectId=caf23606973, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=caf23606973, replyNumber=0, likeNumber=37, createdTime=2014-06-07, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=caf23606973, moduleTitle=ADA 2014：不同GADA滴度LADA患者胰岛β细胞功能变化观察（LADA China 3）研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=caf23606973)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264491, encodeId=7cad1264491c5, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=赛诺菲计划重新提交单抗药Lemtrada sBLA, objectType=article, longId=33001, objectId=59c1330013e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59c1330013e, replyNumber=0, likeNumber=37, createdTime=2014-04-10, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59c1330013e, moduleTitle=赛诺菲计划重新提交单抗药Lemtrada sBLA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=59c1330013e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264492, encodeId=ee761264492d2, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=勃林格殷格翰抗凝血剂Pradaxa新适应症获FDA批准, objectType=article, longId=33005, objectId=a40633005e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a40633005e5, replyNumber=0, likeNumber=37, createdTime=2014-04-10, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a40633005e5, moduleTitle=勃林格殷格翰抗凝血剂Pradaxa新适应症获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a40633005e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264490, encodeId=f33d126449011, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=FDA授予Actelion新型抗生素cadazolid QIDP资格和快速通道地位, objectType=article, longId=31515, objectId=2a6931515b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a6931515b2, replyNumber=0, likeNumber=33, createdTime=2014-03-07, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a6931515b2, moduleTitle=FDA授予Actelion新型抗生素cadazolid QIDP资格和快速通道地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a6931515b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264489, encodeId=06a9126448971, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=JAH：2010年ADA指南或致青少年2型糖尿病漏诊, objectType=article, longId=31365, objectId=9dbb313652a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dbb313652a, replyNumber=0, likeNumber=44, createdTime=2014-03-02, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dbb313652a, moduleTitle=JAH：2010年ADA指南或致青少年2型糖尿病漏诊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dbb313652a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264488, encodeId=f3f11264488b6, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2014 糖尿病指南要点解析, objectType=article, longId=30824, objectId=2d063082470, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d063082470, replyNumber=0, likeNumber=39, createdTime=2014-02-20, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d063082470, moduleTitle=ADA 2014 糖尿病指南要点解析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d063082470)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264487, encodeId=e3c5126448efe, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=2014年ADA糖尿病医学诊疗标准更新要点, objectType=article, longId=28426, objectId=077228426e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=077228426e3, replyNumber=0, likeNumber=34, createdTime=2013-12-23, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=077228426e3, moduleTitle=2014年ADA糖尿病医学诊疗标准更新要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=077228426e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264486, encodeId=5c3b126448678, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=FDA委员会：安全性问题不妨碍赛诺菲MS药物Lemtrada的获批, objectType=article, longId=26815, objectId=d85c2681508, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d85c2681508, replyNumber=0, likeNumber=33, createdTime=2013-11-22, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d85c2681508, moduleTitle=FDA委员会：安全性问题不妨碍赛诺菲MS药物Lemtrada的获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d85c2681508)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264485, encodeId=35a8126448512, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=Circulation：植入式心律转复除颤器对Brugada患者治疗有效, objectType=article, longId=26010, objectId=e40f2601086, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e40f2601086, replyNumber=0, likeNumber=27, createdTime=2013-11-01, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e40f2601086, moduleTitle=Circulation：植入式心律转复除颤器对Brugada患者治疗有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e40f2601086)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264484, encodeId=b0a112644847f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=EASD 2013：西格列汀可保护LADA患者β细胞功能, objectType=article, longId=25260, objectId=5eb72526091, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5eb72526091, replyNumber=0, likeNumber=44, createdTime=2013-10-11, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5eb72526091, moduleTitle=EASD 2013：西格列汀可保护LADA患者β细胞功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5eb72526091)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264483, encodeId=2ead1264483c6, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=FDA接受审查勃林格抗凝血剂Pradaxa sNDA, objectType=article, longId=23542, objectId=75d92354259, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75d92354259, replyNumber=0, likeNumber=34, createdTime=2013-09-01, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75d92354259, moduleTitle=FDA接受审查勃林格抗凝血剂Pradaxa sNDA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75d92354259)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264482, encodeId=155f12644825c, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：甘精胰岛素不增加糖尿病患者癌症风险, objectType=article, longId=22374, objectId=13c2223e4e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c2223e4e7, replyNumber=0, likeNumber=27, createdTime=2013-08-01, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c2223e4e7, moduleTitle=ADA 2013：甘精胰岛素不增加糖尿病患者癌症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13c2223e4e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264481, encodeId=e80a1264481ff, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：周智广：中国自身免疫性糖尿病数量居全球首位, objectType=article, longId=22144, objectId=1efc2214436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1efc2214436, replyNumber=0, likeNumber=34, createdTime=2013-07-28, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1efc2214436, moduleTitle=ADA 2013：周智广：中国自身免疫性糖尿病数量居全球首位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1efc2214436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264480, encodeId=efca1264480c2, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=解读LADA China研究——中国成人自身免疫糖尿病的首项全国性多中心研究, objectType=article, longId=22143, objectId=763e2214388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=763e2214388, replyNumber=0, likeNumber=28, createdTime=2013-07-28, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=763e2214388, moduleTitle=解读LADA China研究——中国成人自身免疫糖尿病的首项全国性多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=763e2214388)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADA

2020-05-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2014：计划委员会主席介绍大会热点

2014-06-15

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

OCC 2014：方丕华教授谈Brugada综合征

2014-06-11

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA2014精彩抢先知

2014-06-11

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2014：降糖：脂肪肝新疗法？

2014-06-11

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2014：第四届ADA-CMT中国专场，欢迎您莅临！

2014-06-07

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2014：中国成人糖尿病流行与控制现状研究

2014-06-07

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2014：不同GADA滴度LADA患者胰岛β细胞功能变化观察（LADA China 3）研究

2014-06-07

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

赛诺菲计划重新提交单抗药Lemtrada sBLA

2014-04-10

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

勃林格殷格翰抗凝血剂Pradaxa新适应症获FDA批准

2014-04-10

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

FDA授予Actelion新型抗生素cadazolid QIDP资格和快速通道地位

2014-03-07

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

JAH：2010年ADA指南或致青少年2型糖尿病漏诊

2014-03-02

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2014 糖尿病指南要点解析

2014-02-20

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

2014年ADA糖尿病医学诊疗标准更新要点

2013-12-23

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

FDA委员会：安全性问题不妨碍赛诺菲MS药物Lemtrada的获批

2013-11-22

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

Circulation：植入式心律转复除颤器对Brugada患者治疗有效

2013-11-01

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

EASD 2013：西格列汀可保护LADA患者β细胞功能

2013-10-11

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

FDA接受审查勃林格抗凝血剂Pradaxa sNDA

2013-09-01

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：甘精胰岛素不增加糖尿病患者癌症风险

2013-08-01

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：周智广：中国自身免疫性糖尿病数量居全球首位

2013-07-28

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

解读LADA China研究——中国成人自身免疫糖尿病的首项全国性多中心研究

2013-07-28

科室
- - 订阅+
  - 更多科室
工具
服务